Health TrialsbyHealthPanel

Effects of Graston Versus Myofascial Release Technique in Patients With Cervicogenic Headache

ConditionCervicogenic Headache
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-40
SponsorRiphah International University

About this trial

Cervicogenic Headache (CGH) is a painful condition that has pronounced impacts on quality and activity of daily lives. It is often associated with decreased mobility, muscular tightness, and postural deviations. When neck muscles become tight, weak, or irritated, they change the way the neck moves and put pressure on nearby joints and nerves. This pressure delivers pain signals to the head, causing a Cervicogenic headache.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Males and females between age 18-40 years [A30.1]of age with Cervicogenic Headache

Diagnosed with Cervicogenic headache according to ICHD-3 criteria (3)

Presence of active myofascial trigger points in the SCM and upper trapezius and subocvcipital levator scapuli (confirmed [A31.1]via palpation and referred pain) simens [A32.1]criteria

Positive Cervical Flexion Rotation Test

Disqualifiers

Any history of cervical trauma, fracture, or recent surgery.

Diagnosis of migraine, tension-type headache, or cluster headache (9).

Any cervical spine pathology e.g. cervical myelopathies and arthropathies.

Pregnant or lactating women.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Graston technique

    Other intervention

    * Applied to: Sternocleidomastoid, Upper trapezius, Levator scapulae, Suboccipitals and cervical paraspinals. * Duration: 5-7 minutes per session, depending on patient tolerance and therapist assessment. * Frequency: 2-3 sessions per week, for 4 weeks

  • Myofascial Release Therapy

    Other intervention

    * Manual release applied to same regions as above using sustained pressure and fascial stretch. * Duration: 7-10 minutes per session. * Frequency: 2-3 sessions per week, for 4 weeks.

Treatment groups

48 Participants
are divided into 2 treatment groups
Group A: Group A: Graston techniqueExperimental treatment 1 intervention
Group B: Group B: Myofascial release therapyActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Neck Disability Index (NDI)

Time frame
upto 4 weeks
2

Numeric Pain Rating Scale (NPRS)

Patient level of pain will be assessed using this scale. This scale ranges from 0 to 10. 0 indicates "no pain" and 10 indicates "worst pain".

Time frame
upto 4 weeks

Secondary outcomes

1

Universal Goniometer (UG)

The range of motion will be measured using universal goniometer that has an inter-rater reliability (ICC2, 2 = 0.79 to 0.92) for cervical region

Time frame
upto 4 weeks
2

Global Rating of Change (GROC) scale

Global Rating of Change (GROC) scale

Time frame
upto 4 weeks

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Riphah International University

Lead sponsor

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: